Krebs Biochemicals & Industries has informed that the board of directors of the Company (the Board) at its meeting held on 22nd October, 2021 and adjourned meeting held on 23rd October, 2021, subject to the approval of the shareholders of the Company, has approved increase in Authorized share capital of the Company and issue/ offer Preference shares.
The above information is a part of company’s filings submitted to BSE.